Quick Answer
Dolby Laboratories, Inc. reported Total Revenue of $1.35 billion for fiscal year 2025.
Dolby Laboratories, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.35B +5.9% |
$1.27B -2.0% |
$1.30B +3.7% |
$1.25B -2.1% |
$1.28B +10.3% |
$1.16B -6.4% |
| Revenue (ASC 606) | $1.35B +5.9% |
$1.27B -2.0% |
$1.30B +3.7% |
$1.25B -2.1% |
$1.28B +10.3% |
$1.16B -6.4% |
| Net Income | $255.02M -2.6% |
$261.82M +30.5% |
$200.66M +9.0% |
$184.09M -40.7% |
$310.23M +34.1% |
$231.36M -9.3% |
| Diluted EPS | $2.62 -2.6% |
$2.69 +31.2% |
$2.05 +13.3% |
$1.81 -39.1% |
$2.97 +32.0% |
$2.25 -7.8% |
| Total Assets | $3.23B +3.8% |
$3.11B +4.4% |
$2.98B +10.8% |
$2.69B -13.4% |
$3.11B +6.5% |
$2.92B +3.4% |
| Cash and Equivalents | $701.89M +45.6% |
$482.05M -35.3% |
$745.36M +20.2% |
$620.13M -49.4% |
$1.23B +14.3% |
$1.07B +34.5% |
| Stockholders Equity | $2.62B +5.9% |
$2.48B +5.2% |
$2.36B +4.8% |
$2.25B -13.5% |
$2.60B +6.8% |
$2.43B +5.4% |
| R&D Expense | $261.79M -0.7% |
$263.66M -2.9% |
$271.52M +4.0% |
$261.17M +3.0% |
$253.64M +6.1% |
$239.04M +0.5% |
| Operating Income | $264.96M +2.6% |
$258.33M +19.7% |
$215.75M +4.4% |
$206.60M -40.0% |
$344.39M +57.4% |
$218.74M -14.9% |
| Gross Profit | $1.19B +4.9% |
$1.13B -1.2% |
$1.15B +3.1% |
$1.11B -3.4% |
$1.15B +13.4% |
$1.02B -6.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $346.71M | -2.9% | +9.9% |
| Revenue (ASC 606) | December 31, 2025 | $346.71M | -2.9% | +9.9% |
| Net Income | December 31, 2025 | $53.33M | -21.4% | +15.7% |
| Diluted EPS | December 31, 2025 | $0.55 | -21.4% | +14.6% |
| Total Assets | December 31, 2025 | $3.19B | +1.1% | -1.1% |
| Cash and Equivalents | December 31, 2025 | $643.85M | +23.6% | -8.3% |
| Stockholders Equity | December 31, 2025 | $2.59B | +3.4% | -1.1% |
| R&D Expense | December 31, 2025 | $69.08M | +3.7% | +4.7% |
| Operating Income | December 31, 2025 | $62.16M | -22.2% | +30.5% |
| Gross Profit | December 31, 2025 | $303.50M | -4.0% | +11.8% |
- Dolby Laboratories, Inc. reported Total Revenue of $1.35 billion for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +5.9% in Total Revenue compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Revenue (ASC 606) of $1.35 billion for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +5.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Net Income of $255.02 million for fiscal year 2025.
- Dolby Laboratories, Inc. showed a decrease of -2.6% in Net Income compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Diluted EPS of $2.62 per share for fiscal year 2025.
- Dolby Laboratories, Inc. showed a decrease of -2.6% in Diluted EPS compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Total Assets of $3.23 billion for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +3.8% in Total Assets compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Cash and Equivalents of $701.89 million for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +45.6% in Cash and Equivalents compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Stockholders Equity of $2.62 billion for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +5.9% in Stockholders Equity compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported R&D Expense of $261.79 million for fiscal year 2025.
- Dolby Laboratories, Inc. showed a decrease of -0.7% in R&D Expense compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Operating Income of $264.96 million for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +2.6% in Operating Income compared to the prior fiscal year.
- Dolby Laboratories, Inc. reported Gross Profit of $1.19 billion for fiscal year 2025.
- Dolby Laboratories, Inc. showed an increase of +4.9% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: